ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,346,476 | -27.1% | 92,237 | -42.2% | 0.09% | -32.1% |
| Q2 2023 | $62,168,950 | +71.1% | 159,518 | +63.6% | 0.14% | +50.5% |
| Q1 2023 | $36,335,865 | +36.2% | 97,525 | +38.5% | 0.09% | +24.7% |
| Q4 2022 | $26,679,103 | -21.4% | 70,425 | -26.8% | 0.07% | -29.8% |
| Q3 2022 | $33,954,000 | -35.3% | 96,172 | -30.6% | 0.10% | -39.2% |
| Q2 2022 | $52,474,000 | +831.9% | 138,497 | +675.5% | 0.17% | +850.0% |
| Q1 2022 | $5,631,000 | +45.1% | 17,860 | +38.9% | 0.02% | +12.5% |
| Q3 2021 | $3,882,000 | – | 12,854 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |